Cytokine response to diabetic ketoacidosis and its treatment

Clinical Immunology

Volumn 108, Issue 3, 2003, Pages 175-181

  Hoffman, William H ^a   Burek, C Lynne ^b   Waller, Jennifer L ^a   Fisher Jr , Lyle E ^a   Khichi, Mahmood ^a   Mellick, Larry B ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cellular activation; Cytokines; Diabetic ketoacidosis

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; BRAIN EDEMA; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; DIABETIC KETOACIDOSIS; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LUNG EDEMA; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0141788730     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-6616(03)00144-X     Document Type: Article

References (42)

1. Hoffman W.H., Steinhart C.M., El Gammal T., Steele S., Cuadrado A.R., Morse P.K. Cranial computed tomography in children and adolescents with diabetic ketoacidosis. Am. J. Neuroradiol. 9:1988;733-739.
2. Durr J.A., Hoffman W.H., Sklar A.H., El Gammal T., Steinhart C.M. Correlates of brain edema in uncontrolled insulin-dependent diabetes. Diabetes. 41:1992;627-632.
3. Hoffman W.H., Locksmith J.P., Burton E.M., Hobbs E., Passmore G.G., Pearson-Shaver A.L. Interstitial pulmonary edema in children and adolescents with diabetic ketoacidosis. J. Diabetes Complications. 12:1998;314-320.
4. Edge J.A., Ford-Adams M.E., Dunger D.B. Causes of death in children and young people with diabetes mellitus. Arch. Dis. Child. 81:1999;318-323.
5. Breidbart S., Singer L., St. Louis Y., Saenger P. Adult respiratory distress syndrome in an adolescent with diabetic ketoacidosis. J. Pediatr. 111:1987;736-738.
6. Keane S., Gallagher A., Ackroyd S., McShane M.A., Edge J.A. Cerebral venous thrombosis during diabetic ketoacidosis. Arch. Dis. Child. 86:2002;204-206.
7. Hale P.M., Rezvani I., Braunstein A.W. Factors predicting cerebral edema in young children with diabetic ketoacidosis and new onset Type 1 diabetes. Acta. Paediatr. 86:1997;626-631.
8. Glaser N., Barnett P., McCaslin I., Nelson D., Trainor J., Louie J., Kaufman F., Quayle K., Roback M., Malley R., Kupperman N. Risk factors for cerebral edema in children with diabetic ketoacidosis. N. Engl. J. Med. 344:2001;264-269.
9. Isales C.M., Min L., Hoffman W.H. Acetoacetate and B-hydroxybutyrate differentially regulate endothelin-1 and vascular endothelial growth factor in mouse brain microvascular endothelial cells. J. Diabetes Complications. 13:1999;91-97.
10. Hoffman W.H., Cheng C., Passmore G.G., Carroll J.E., Hess D. Acetoacetate increases expression of intercellular adhesion molecule-1 (IDAM-1) in human brain microvascular endothelial cells. Neurosci. Lett. 334:2002;71-74.
11. Hoffman W.H., Helman S.W., Passmore G.G. Acute activation of peripheral lymphocytes during treatment of diabetic ketoacidosis. J. Diabetes Complications. 15:2001;144-149.
12. Slifka M.K., Whitton J.L. Clinical implications of dysregulated cytokine production. J. Mol. Med. 78:2000;74-80.
13. Yeh F.L., Lin W.L., Shen H.D. Changes in circulating levels of an anti-inflammatory cytokine interleukin 10 in burned patients. Burns. 26:2000;454-459.
14. Hensler T., Hecker H., Heeg K., Heidecke C.-D., Bartels H., Barthlen W., Wagner H., Siewert J.-R., Holzmann B. Distinct mechanisms of immunosuppression as a consequence of major surgery. Infect. Immun. 65:1997;2283-2291.
15. Meduri G.U., Headley S., Kohler G., Stentz F., Tolley E., Umberger R., Leeper K. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Chest. 107:1995;1062-1073.
16. Martin C., Boisson C., Haccoun M., Thomachot L., Mege J.-L. Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock and severe trauma. Crit. Care Med. 25:1997;1813-1819.
17. Hehmke B., Michaelis D., Gens E., Laube F., Kohnert K.D. Aberrant activation of CD4 + T-cell and CD8 + T-cell subsets in patients with newly diagnosed IDDM. Diabetes. 44:1995;1414-1419.
18. Hanninen A., Jalkanen S., Salmi M., Toikkanen S., Nekolakaros G., Sinell O., Macrophages T. cell receptor usage and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus. J. Clin. Invest. 90:1992;1901-1910.
19. Mandrup-Poulsen T. The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia. 39:1996;1005-1029.
20. Green E.A., Eynon E.E., Flavell R.A. Local expression of TNF alpha in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens. Immunity. 9:1998;733-743.
21. Abu El Asar A.M., Maimone D., Morse P.H., Gregory S., Reder A.T. Cytokines in the vitreous of patients with proliferative diabetic retinopathy. Am. J. Ophthalmol. 114:1992;731-736.
22. Younger D.S., Rosoklija G., Hays A.P., Trojaborg W., Latov N. Diabetic peripheral neuropathy A clinicopathologic and immunohistochimical analysis of sural nerve biopsies . Muscle & Nerve. 19:1996;722-727.
23. Lechleitner M., Koch T., Herold M., Dzien A., Hoppichler F. Tumor necrosis factor-alpha plasma level in patients with type 1 diabetes mellitus and its association with glycaemic control and cardiovascular risk factors. J. Intern. Med. 248:2000;67-76.
24. Espersen G.T., Mathiesen O., Grunnet N., Jensen S., Ditzel J. Cytokine plasma levels and lymphocyte subsets in patients with newly diagnosed insulin-dependent diabetes mellitus before and following initial insulin treatment. APMIS. 101:1993;703-706.
25. Erbagci A.B., Tarakcioglu M., Coskun Y., Sivasli E., Namiduru E.S. Mediators of inflammation with type 1 diabetes mellitus Cytokines in type 1 diabetic children . Clin. Biochem. 34:2001;645-650.
26. Downing L.J., Strieter R.M., Kadell A.M., Wilke C.A., Austin J.C., Hare B.D., Burdick M.D., Greenfield L.J., Wakefield T.W. IL-10 regulates thrombus-induced vein wall inflammation and thrombosis. J. Immunol. 161:1998;1471-1476.
27. Sato S., Suzuki T., Okada K. Suppression of mitogenic response of bovine peripheral blood lymphocytes by ketone bodies. J. Vet. Med. Sci. 57:1995;183-185.
28. Cook-Mills J.M., Cohen R.L., Perlman R.L., Chambers D.A. Inhibition of lymphocyte activation by catecholamines Evidence for a nonclassical mechanism of catecholamine action . Immunology. 85:1995;544-549.
29. Sedgwick J.B., Menon I., Gern J.E., Busse W.W. Effects of inflammatory cytokines on the permeability of human lung microvascular endothelial cell monolayers and differential eosinophil transmigration. J. Allergy Clin. Immunol. 110:2002;752-756.
30. Friedl J., Puhlmann M., Bartlett D.L., Libutti S.K., Turner E.N., Grant M.F., Alexander H.R. Induction of permeability across endothelial cell monolayers by tumore necrosis factor (TNF) occurs via a tissue factor-independent mechanism Relationship between procoagulant and permeability effects of TNF . Blood. 1000:2002;1334-1339.
31. Funatsu H., Yamashita H., Noma H., Minura T., Yamashita T., Hori S. icreased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with vascular edema. Am. J. Ophthalmol. 133:2002;70-77.
32. Baluna R., Vitetta E.S. Vascular leak syndrome A side effect of immunotherapy . Immunopharmacology. 37:1997;117-132.
33. Pezzili R., Billi P., Miniero R., Barakat B. Serum interleukin-10 in human acute pancreatitis. Dig. Dis. Sci. 42:1997;1469-1472.
34. Yeh F.L., Lin W.L., Shen H.D., Fang R.H. Changes in serum tumor necrosis factor-alpha in burned patients. Burns. 23:1997;6-10.
35. Yeh F.L., Lin W.L., Shen H.D., Fang R.H. Changes in levels of serum IL-8 in burned patients. Burns. 23:1997;555-559.
36. Yeh F.L., Lin W.L., Shen H.D., Fang R.H. Changes in circulating levels of interleukin 6 in burned patients. Burns. 25:1999;131-136.
37. Dantzer R., Konsman J.P., Bluthe R.M., Kelley K.W. Neural and hormonal pathways of communication from the immune system to the brain Parallel or convergent? Auton. Neurosci. 85:2000;60-65.
38. Ek M., Eugblom D., Saha S., Blomqvist A., Jackobsson P.J., Ericason-Dahlstrand A. Inflammatory response pathway across the blood brain barrier. Nature. 410:2001;430-431.
39. Buttini M., Baddeka H. Peripheral lipopolysaccharide stimulation induces interleukin-1B messenger RNA in rat brain microglial cells. Neuroscience. 65:1995;523-530.
40. Buttini M., Mir A., Appel K., Wiederhold K.H., Limonta S., Gebicki-Haerter P.-J., Boddeke H.W.G.M. Lipoplysaccharide induces expression of tumor necrosis factors alpha in rat brain Inhibition by methylprednisolone and by rolipram . Br. J. Pharmacol. 122:1997;1483-1489.
41. Anthony D.C., Bolton S.J., Feam S., Ferry V.H. Age-related effects of interleukin-1B on polymorphonuclear neutrophil-dependent increases in blood-brain barrier permeability in rats. Brain. 120:1997;435-444.
42. Alkharfy K.M., Kellum J.A., Matzke G.R. Unintended immunomodulation Part 1. Effects of common clinical conditions on cytokine biosynthesis . Shock. 13:2000;333-345.